Clinical trial · Interventional
Vicryl Plus and Monocryl Plus in Breast Surgery
Pilot Study of Vicryl Plus and Monocryl Plus in Breast Surgery
NCT00830271CI-TRIAL-00043101completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a randomised pilot study comparing conventional sutures (Vicryl and Monocryl) with antiseptic coated equivalents (Vicryl plus andf Monocryl plus) in elective breast surgery.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer Surgery | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Vicryl plus and Monocryl plus | Device | — | UNRESOLVED |
| wound closure with Vicryl and Monocryl | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Vicryl plus/Monocryl plus
- description
- Vicryl plus and Monocryl plus is the active comparator arm. These are the "active" sutures, coated with triclosan antiseptic, being used in the closure of skin and subcutaneous tissues after breast cancer surgery.
- interventionNames
- Device: Vicryl plus and Monocryl plus
- type
- PLACEBO_COMPARATOR
- label
- vicryl/monocryl
- description
- "Plain" Vicryl or Monocryl suture currently the standard which are not coated with triclosan, serve as the control.
- interventionNames
- Device: wound closure with Vicryl and Monocryl
Primary outcomes (1)
- measure
- reduction of surgical site infection
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * All patients over 18 years old who attend the Cardiff and Vale NHS Trust for elective breast cancer surgery Exclusion Criteria: * patients unable to give consent or comply with follow up * patients undergoing surgery for benign disease * patients with inflammatory cancers or skin ulceration * patients having neo-adjuvant chemotherapy or radiotherapy * patients with known allergy to triclosan antiseptic * patients with immune deficiency diseases
References
Publications (0)
Data not yet available
No reference posted for this study.